NICE has cleared the way for bevacizumab to be used by the NHS to treat colorectal cancer for the first time, thanks to the availability of lower-cost biosimilar versions of the drug. In recently ...

Imvax has shrugged off the failure of its phase 2b brain cancer trial to hit its primary endpoint, reporting evidence of improved overall survival (OS) and making a beeline for the FDA. The study ...

Czech generic drugmaker Zentiva said on Thursday that private equity group Advent International had agreed to sell the company to rival GTCR for an undisclosed value, per a Reuters report. The report ...

Kirkland & Ellis has advised longtime client GTCR on its €4.1 billion (US$4.8 billion) acquisition of European pharmaceutical giant Zentiva who relied on Freshfields’ counsel. Private equity firm GTCR ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Wall Street banks including Goldman Sachs Group Inc. and ...

Sept 11 (Reuters) - Czech generic drugmaker Zentiva (1SKF401E.BV), opens new tab said on Thursday that private equity group Advent International had agreed to sell the company to rival GTCR for an ...

Buyout firm GTCR agreed to acquire generic drugmaker Zentiva Group AS from Advent, adding to a flurry of health-care deals this year. The transaction is expected to be completed by early 2026, ...

Following CapVest Partners' takeover of Germany’s Stada earlier this month, another private equity group is looking to cash in on Europe’s generic medicines manufacturing scene. Chicago-based ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Buyout firm GTCR agreed to acquire generic drugmaker ...

Sept 10 (Reuters) - Private equity firm GTCR has struck a 4.1 billion euro ($4.8 billion) deal to buy Czech generic drugmaker Zentiva (1SKF401E.BV), opens new tab from Advent International, the ...

(Reuters) - Private equity firm GTCR has struck a 4.1 billion euro ($4.8 billion) deal to buy Czech generic drugmaker Zentiva from Advent International, the Financial Times reported on Wednesday, ...